Abstract:Hypoxia is a common characteristic of solid tumors. This important feature is associated with resistance to radio-chemotherapy, which results in poor prognosis and probability of tumor recurrence. Taking advantage of background-free NIR II fluorescence imaging and deeper-penetrating photoacoustic (PA) imaging, we developed a hypoxia-triggered and nitroreductase (NTR) enzyme-responsive single molecule probe for high-contrast NIR II/PA tumor imaging and hypoxia-activated photothermal therapy (PTT), which will overcome cellular resistance during hypoxia. Methods: The single molecule probe IR1048-MZ was synthesized by conjugating a nitro imidazole group as a specific hypoxia trigger with an IR-1048 dye as a NIR II/PA signal reporter. We investigated the NIR II fluorescence, NIR absorbance and photothermal effect in different hypoxia conditions in vitro, and performed NIR II/PA tumor imaging and hypoxia-activated photothermal therapy in mice. Results: This versatile molecular probe IR1048-MZ not only realized high-contrast tumor visualization with a clear boundary by NIR II fluorescence imaging, but also afforded deep-tissue penetration at the centimeter level by 3D PA imaging. Moreover, after being activated by NTR that is overexpressed in hypoxic tumors, the probe exhibited a significant photothermal effect for curative tumor ablation with no recurrence. Conclusions: We have developed the first hypoxia-triggered and NTR enzyme-responsive single molecule probe for high-contrast NIR II/PA tumor imaging and hypoxia-activated photothermal therapy. By tracing the activity of NTR, IR1048-MZ may be a promising contrast agent and theranostic formulation for other hypoxia-related diseases (such as cancer, inflammation, stroke, and cardiac ischemia).

Iridium Complex, a Phosphorescent Light-Emitting Diode Material, Serves As a Novel Chemical Probe for Imaging Hypoxic Tumor Tissues

Confocal microscopic oxygen imaging of xenograft tumors using Ir(III) complexes as in vivo intravascular and intracellular probes

A Novel Luminescent Ir(iii) Complex for Dual Mode Imaging: Synergistic Response to Hypoxia and Acidity of the Tumor Microenvironment

A Novel Phosphorescent Iridium(iii) Complex Bearing a Donor-Acceptor-type O-Carboranylated Ligand for Endocellular Hypoxia Imaging

A Cyclodextrin‐Hosted Ir(III) Complex for Ratiometric Mapping of Tumor Hypoxia In Vivo

Successively Activatable Ultrasensitive Probe for Imaging Tumour Acidity and Hypoxia

Hypoxia-sensitive Bis(2-(2'-benzothienyl)pyridinato-n,c(3'))iridium[poly(n-butyl Cyanoacrylate]/chitosan Nanoparticles and Their Phosphorescence Tumor Imaging in Vitro and in Vivo.

Phosphorescent Ir(III) complexes conjugated with oligoarginine peptides serve as optical probes for in vivo microvascular imaging

Zwitterionic Iridium Complexes: Synthesis, Luminescent Properties, and Their Application in Cell Imaging.

Phosphorescence Monitoring of Hypoxic Microenvironment in Solid-Tumors to Evaluate Chemotherapeutic Effects Using the Hypoxia-Sensitive Iridium (III) Coordination Compound.

Phosphorescent iridium(iii) complexes capable of imaging and distinguishing between exogenous and endogenous analytes in living cells.

"Turn-On" Activatable AIE Dots for Tumor Hypoxia Imaging.

Hypoxia-triggered single molecule probe for high-contrast NIR II/PA tumor imaging and robust photothermal therapy

Hypoxia-activated probe for NIR fluorescence and photoacoustic dual-mode tumor imaging

NIR‐II J‐Aggregated Pt(II)‐Porphyrin‐Based Phosphorescent Probe for Tumor‐Hypoxia Imaging

Highly Bright Near-Infrared Chemiluminescent Probes for Cancer Imaging and Laparotomy.

Tumor-specific Fluorescence Activation of Rhodamine Isothiocyanate Derivatives.

Hypoxia-Responsive Molecular Probe Lighted up by Peptide Self-Assembly for Cancer Cell Imaging

An Organophosphorescence Probe with Ultralong Lifetime and Intrinsic Tissue Selectivity for Specific Tumor Imaging and Guided Tumor Surgery

Dual‐Emissive Iridium(III) Complexes and Their Applications in Biological Sensing and Imaging

Selective Imaging of Cancer Cells with a Ph-Activatable Lysosome-Targeting Fluorescent Probe.